450 participants
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-03
- Start Date:
- 2024-03-12
- Completion:
- 2028-04-25
Conditions
- Oligometastatic Prostate Cancer (OMPC)
Interventions
- DRUG
No Results Yet